tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

DE:4AB Stock Latest News

AbbVie Reports Solid 2024 Financial Results Amid Challenges
Company AnnouncementsAbbVie Reports Solid 2024 Financial Results Amid Challenges
1h ago
ABBV
Apple, Intel little changed near noon following earnings: Morning Buzz
PremiumThe Fly
Apple, Intel little changed near noon following earnings: Morning Buzz
12h ago
V
Z
AbbVie rises 7.8%
PremiumThe Fly
AbbVie rises 7.8%
14h ago
ABBV
Early notable gainers among liquid option names on January 31st
PremiumThe Fly
Early notable gainers among liquid option names on January 31st
14h ago
BKR
EMN
AbbVie rises 7.4%
PremiumThe Fly
AbbVie rises 7.4%
14h ago
ABBV
Unusually active option classes on open January 31st
PremiumThe FlyUnusually active option classes on open January 31st
14h ago
EA
CLS
AbbVie sees Q1 adjusted EPS $2.47-$2.51, consensus $2.59
Premium
The Fly
AbbVie sees Q1 adjusted EPS $2.47-$2.51, consensus $2.59
14h ago
ABBV
AbbVie sees FY25 adjusted gross margin 84% of sales
Premium
The Fly
AbbVie sees FY25 adjusted gross margin 84% of sales
14h ago
ABBV
AbbVie seeing ‘significant advancements’ across entire pipeline
PremiumThe Fly
AbbVie seeing ‘significant advancements’ across entire pipeline
14h ago
ABBV
AbbVie sees FY25 revenue ~$59B, consensus $59.07B
PremiumThe Fly
AbbVie sees FY25 revenue ~$59B, consensus $59.07B
14h ago
ABBV
AbbVie expects Humira access to decrease throughout 2025
PremiumThe Fly
AbbVie expects Humira access to decrease throughout 2025
15h ago
ABBV
AbbVie says ‘very pleased’ with progress in 2024, sees ‘strong growth’ in 2025
PremiumThe Fly
AbbVie says ‘very pleased’ with progress in 2024, sees ‘strong growth’ in 2025
15h ago
ABBV
Morning Movers: Apple and Exxon higher following quarterly earnings
PremiumThe FlyMorning Movers: Apple and Exxon higher following quarterly earnings
15h ago
V
CL
AbbVie reports Q4 adjusted EPS $2.16, consensus $2.26
Premium
The Fly
AbbVie reports Q4 adjusted EPS $2.16, consensus $2.26
16h ago
ABBV
AbbVie sees FY25 adjusted EPS $12.12-$12.32, consensus $12.13
Premium
The Fly
AbbVie sees FY25 adjusted EPS $12.12-$12.32, consensus $12.13
16h ago
ABBV
AbbVie backs high single-digit compound annual revenue growth through 2029
PremiumThe Fly
AbbVie backs high single-digit compound annual revenue growth through 2029
16h ago
ABBV
Notable companies reporting before tomorrow’s open
PremiumThe Fly
Notable companies reporting before tomorrow’s open
1d ago
CL
BAH
Wells downgrades Vertex to Equal Weight on lack of catalysts
PremiumThe Fly
Wells downgrades Vertex to Equal Weight on lack of catalysts
2d ago
LLY
ABBV
ABBV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ABBV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3d ago
ABBV
AbbVie price target lowered to $205 from $215 at Citi
PremiumThe FlyAbbVie price target lowered to $205 from $215 at Citi
4d ago
ABBV
AbbVie price target raised to $227 from $220 at Piper Sandler
Premium
The Fly
AbbVie price target raised to $227 from $220 at Piper Sandler
5d ago
ABBV
AbbVie completes acquisition of Nimble Therapeutics
Premium
The Fly
AbbVie completes acquisition of Nimble Therapeutics
9d ago
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >